Chinese english Japanese Germany Korea
ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >2-chloro-N-(2,4-dimethylphenyl)acetamide

2-chloro-N-(2,4-dimethylphenyl)acetamide

2-chloro-N-(2,4-dimethylphenyl)acetamide Structure
CAS No.
39106-10-0
Chemical Name:
2-chloro-N-(2,4-dimethylphenyl)acetamide
Synonyms
Lidocaine-012;Lidocaine Impurity L;Lidocaine Impurity 13;Lidocaine hydrochloride impurity903;Chloro-N-(2,4-dimethylphenyl)acetamide;N-(2,4-Dimethylphenyl)-2-chloroacetamide;2-chloro-N-(2,4-dimethylphenyl)ethanamide;Acetamide, 2-chloro-N-(2,4-dimethylphenyl)-;JR-8653, 2-Chloro-N-(2,4-dimethylphenyl)acetamide, 97%;2-chloro-N-(2,4-dimethylphenyl)acetamide(SALTDATA: FREE)
CBNumber:
CB6908807
Molecular Formula:
C10H12ClNO
Molecular Weight:
197.66
MOL File:
39106-10-0.mol
MSDS File:
SDS
Modify Date:
2024/5/21 14:26:55
Request For Quotation

2-chloro-N-(2,4-dimethylphenyl)acetamide Properties

Melting point 144-146 °C(Solv: ethanol (64-17-5))
Boiling point 331.1±30.0 °C(Predicted)
Density 1.187±0.06 g/cm3(Predicted)
storage temp. Refrigerator
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka 12.91±0.70(Predicted)
color White to Off-White
EPA Substance Registry System Acetamide, 2-chloro-N-(2,4-dimethylphenyl)- (39106-10-0)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS05
Signal word  Danger
Hazard statements  H318-H335-H315-H302
Precautionary statements  P280-P305+P351+P338-P310-P264-P270-P301+P312-P330-P501-P264-P280-P302+P352-P321-P332+P313-P362

2-chloro-N-(2,4-dimethylphenyl)acetamide Chemical Properties,Uses,Production

Uses

N-(2,4-Dimethylphenyl)-2-chloroacetamide is an intermediate in the synthesis of Tetrahydrophthalimide derivative as inhibitors of HIV-1 reverse transcriptase.

2-chloro-N-(2,4-dimethylphenyl)acetamide Preparation Products And Raw materials

Raw materials

Preparation Products

2-chloro-N-(2,4-dimethylphenyl)acetamide Suppliers

Global( 60)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
AnalyticsStanza Inc +91-7032031309 +91-7032031309 Hyderabad, India 227 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
ANHUI WITOP BIOTECH CO., LTD +8615255079626 China 23556 58 Inquiry
sgtlifesciences pvt ltd +8617013299288 China 12382 58 Inquiry
ShenZhen H&D Pharmaceutical Technology Co., LTD +86-0755-22677845 +86-13627253706 China 3302 58 Inquiry
Bide Pharmatech Ltd. 400-1647117 15221909166 China 63720 58 Inquiry
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212 China 6789 58 Inquiry
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053 China 1892 58 Inquiry
Changzhou Qianai Biotechnology Co., Ltd 0519-15240519135 13961152745 China 5293 58 Inquiry
PureChemland Co.,Ltd. 19936016343 China 3536 58 Inquiry
Supplier Advantage
AnalyticsStanza Inc 58
Pharmaffiliates Analytics and Synthetics P. Ltd 58
ANHUI WITOP BIOTECH CO., LTD 58
sgtlifesciences pvt ltd 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 58
Bide Pharmatech Ltd. 58
Nanjing Huanuo Biomedical Technology Co., Ltd 58
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 58
Changzhou Qianai Biotechnology Co., Ltd 58
PureChemland Co.,Ltd. 58

39106-10-0(2-chloro-N-(2,4-dimethylphenyl)acetamide )Related Search:

Tofacitinib Impurity 2 Tofacitinib Impurity 45 Tofacitinib Related Compound 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Tofacitinib Impurity N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 36 Tofacitinib Impurity N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
chevron_left

1of4

chevron_right
Chloro-N-(2,4-dimethylphenyl)acetamide N-(2,4-Dimethylphenyl)-2-chloroacetamide 2-chloro-N-(2,4-dimethylphenyl)acetamide(SALTDATA: FREE) 2-chloro-N-(2,4-dimethylphenyl)ethanamide Acetamide, 2-chloro-N-(2,4-dimethylphenyl)- JR-8653, 2-Chloro-N-(2,4-dimethylphenyl)acetamide, 97% Lidocaine impurity 21/2-Chloro-N-(2,4-dimethylphenyl)acetamide Lidocaine-012 Lidocaine Impurity 13 Lidocaine Impurity L Lidocaine hydrochloride impurity903 39106-10-0